Dr. Colciago started her career in digital health investments in 2017, when she joined MTIP, a Swiss-based investment team focused on healthtech startups. Her passion for digital health goes back to 2007 when, during her university studies, she worked along the academic team pioneering the application of advanced mathematical techniques to medical problems.
She has a Ph.D. in Applied Mathematics from the École Polytechnique fédérale de Lausanne (EPFL) in Switzerland. Her thesis was focused on fluid-structure interaction simulations of cardiovascular problems and her work has been published in major scientific journals.
During her post-doc studies, she led a proof of concept project of a digital health startup. She managed and contributed to the development of risk assessment software for vascular surgeons. In 2017, she obtained a certificate of advanced studies in “Management of medtech, biotech and pharma ventures” from EPFL.
During her years at MTIP, before joining Takeda, she led a $20+m financing round in Oviva and led/supported the first and/or follow-on investment in other portfolio companies such as Coramaze, Blueprint Genetics, Tyto Care, Lumeon, and Cynerio. She served as a board member in Coramaze. She has been invited as a panelist and jury member at international healthtech startups conferences.
Outside work, she spends time reading books, playing, and singing with her daughter and husband. She trains her problem-solving skills in the bouldering gym and she is passionate about mountaineering.